OUR OUR
40 th YEAR YEAR
ISSN 1068-1760
I
N
T
Diagnosing Allergic Reaction in Kidneys
A
cute tubulointerstitial nephritis (AIN) is a medical condition that causes inflammation of the kidneys and can result in acute kidney injury (AKI) — a rapid deterioration of kidney function. Medications used for treating gastroesophageal reflux
Cont’d on page 3
Vol.40 No.5 • 8-9/2023
E
F
R
N
A
T
I
DAILY CLINICAL LAB NEWS
®
O
New Platform Brings Power of Multiplex Imaging to Clinical Pathology
or over a hundred years, pathologists have relied on histology, a method that involves examining cells and tissues under a microscope to identify cancerous patterns. Now, a new tool promises to improve this process by providing deep insights into the
cancerous tissue. By combining histological and molecular data, the tool can provide a deeper understanding of the type, behavior, and probable response to the treatment of a tumor. The tool, named Orion, is the product of extensive research and Cont’d on page 13
AACC 2023 Roundup: Highlights of Technical Exhibition T
S
I
T
LINKXPRESS COM
R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information: Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
A
L
Candida Auris Test Takes Only 3-5 Hours
C
andida auris (C. auris) is a fungal pathogen resistant to multiple drugs and is recognized as a significant worldwide health risk due to its high mortality rate of up to 60%. Its identification is challenging with conventional lab techniques, often leading to improper treatment. To reduce the burden of this fungal disease, public health officials are being urged to continue promoting the
Test Predicts Response to Immunotherapy
I
n recent years, there has been a significant increase in clinical trials for new cancer drugs. However, only a select group of patients have found success with these newer immunotherapies, which utilize the patient’s immune response to combat cancer. Currently, predicting a patient’s response to therapy depends on isolated, single-analyte biomarkers, which have proven
See article on page 4
I
N
Cont’d on page 11
he world’s largest exhibition of in vitro diagnostics was held on July 23-27, 2023, at Anaheim, California. LabMedica’s editors present a comprehensive review of showcased innovations shaping the future of clinical testing.
V
V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER
Cont’d on page 10
Rapid Molecular Test Detects 8 Common GI Parasites
G
astrointestinal (GI) infections are a significant health concern, causing illness and mortality, especially in developing countries where they claim the lives of approximately two million children under five each year. Gastroenteritis, a common GI illness, can be caused by various Cont’d on page 14
Mindray to Acquire 75% Stake in DiaSys
M
indray (Shenzhen, China; www.mindray.com) has agreed to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH (Holzheim, Germany; www.diasys-diagnostics.com) through its Dutch subsidiary for an all-cash preliminary purchase price of approximately EUR 115
million with the final amount to be determined as of closing. The agreement is slated to be finalized later this year, pending regulatory approvals and the granting of regulatory approvals. Upon finalizing the transaction, Mindray will hold a 75% stake in DiaSys and conCont’d on page 6
INSIDE
AACC ’23 Roundup . . . 4 LabMedica EXPO . 6-16 Clinical News . . . 10-20 IFCC News . . . . 17-19 Industry News .. . . . 21 Events Calendar . . 22 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<